VIRADAY TABLET

VIRADAY TABLET

DESCRIPTION

  • Composition : Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
  • Manufacturer: Cipla
  • Indication: Anti HIV
  • Packaging: Bottle
  • Dosage Form: Tablet

PACKAGE

  • 200mg
  • 300mg
  • 600mg
Category:

Brand Name: Viraday
Generic Name: Emtricitabine+Tenofovir disoproxil fumarate+Efavirenz
Manufacturer: Cipla
Dosage Form: Tablet
Strength: 200mg/300mg/600mg
Composition: Emtricitabine(200mg) + Tenofovir disoproxil fumarate(300mg) + Efavirenz(600mg)
Indication: HIV
Packaging: 30 tablets
Storage: Store at room temperature

Overview Of Viraday Tablet
Viraday (Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz) tablet is a combination of three antiretroviral medications. It is used for the treatment of HIV (human immunodeficiency virus) infection. This medication belongs to a class of medication known as nucleoside reverse transcriptase inhibitors (NRTIs). Viraday tablet boosts your immune system to fight against infection and helps to reduce the amount of HIV in your body and improves the quality of life. It is important to take Viraday tablet as prescribed by your doctor. Do not take this medicine in the wrong way as it may lead to some serious side effects.

Pharmacodynamics
Emtricitabine (Viraday):- a synthetic nucleoside analog of cytidine, is phosphorylated by cellular enzymes to form emtricitabine 5′-triphosphate. It inhibits the activity of the HIV-1 reverse transcriptase (RT) by competing with the natural substrate deoxycytidine 5′-triphosphate and by being incorporated into nascent viral DNA which results in chain termination. Emtricitabine is a weak inhibitor of mammalian DNA polymerase alpha, beta, epsilon, and mitochondrial DNA polymerase gamma.

Tenofovir Disoproxil Fumarate (Viraday):- Tenofovir disoproxil fumarate is an acyclic nucleoside phosphonate diester analog of adenosine monophosphate. Tenofovir disoproxil fumarate requires initial diester hydrolysis for conversion to tenofovir and subsequent phosphorylations by cellular enzymes to form tenofovir diphosphate. It inhibits the activity of HIV-1 RT by competing with the natural substrate deoxyadenosine 5′-triphosphate and, after incorporation into DNA, by DNA chain termination.

Efavirenz (Viraday):- belongs to the NNRTI (non-nucleoside reverse transcriptase inhibitors) class of antiretrovirals. Both nucleoside and non-nucleoside RTIs inhibit the same target, the reverse transcriptase enzyme, an essential viral enzyme that transcribes viral RNA into DNA. Unlike nucleoside RTIs, which bind at the enzyme’s active site, NNRTIs act allosterically by binding to a distinct site away from the active site known as the NNRTI pocket.

Usage
Viraday tablet is a combination of three anti-HIV medicines: Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz. This medication is not a permanent cure for HIV infection. It only prevents the multiplication of HIV (human immunodeficiency virus) infection in human cells. The recommended dose of Viraday medicine is decided by a doctor according to your previous medical condition and response to the treatment. It is advisable not to change your regular dosing schedule without taking suggestions from your doctor. If you experience any signs and symptoms while receiving Viraday tablet, inform your doctor immediately.

Interactions
Viraday tablets can interact with other medications and it may increase the risk for side effects. Don’t forget to disclose and discuss your previous medical history with the doctor.

Medicine Interactions
Fluconazole

Gentamicin

Cisplatin

Amiodarone

Leflunomide

Aspirin

Azithromycin

Tobramycin

Ciprofloxacin

Disease Interactions
Renal dysfunction

Hepatic impairment

CNS disorders

Alcohol Interaction
Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol.

Contraindication
Do not use this medicine if you are allergic to Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz

Viraday tablet is not recommended in patients known to be hypersensitive.

Alternate Brands
Teefavir
Teevir

Side Effects Of Viraday Tablet
This medicine may cause some common side effects. Discuss the risks and benefits of the Viraday tablets with the doctor before starting the treatment.

Common Side Effects
Dizziness

Unusual sweating

Skin rash

Itching

Indigestion

Constipation

Redness of skin

Headache

Taste change

Blurred vision

Confusion

Weight loss

Sweating

Mood changes

Nausea

Fever

Chills

Nightmare

Stomach ache

Diarrhea

Blood in urine

Irregular heartbeat

Abnormal dream

Confusion

Muscle pain

Note – immediately contact your health care provider if any side effects occur.

Dosage
Take this medicine as prescribed by your doctor. Do not stop or skip your regular dosing schedule.

Missed Dose
It is advisable not to miss a dose. If you miss a scheduled dose of Viraday tablets, contact your doctor immediately.

Overdose
In case of an overdose of Viraday tablets, the doctor will provide emergency medical treatment.

Warnings
Before starting treatment with Viraday medicine, please inform your doctor about your previous medical history. If you experience any signs and symptoms while receiving this medication, do not ignore those symptoms because it may lead to higher risk.

Contraception

Use suitable methods of contraception to prevent pregnancy while taking Viraday medicine.

Children and adolescents

Viraday tablets are not recommended for use in children under the age of 18.

Warnings For Female
Pregnancy

Do not use Viraday medicine if you are planning to become pregnant. Avoid this medication at the time of pregnancy.

Breastfeeding

This medicine is not recommended in breastfeeding unless it is required. Please consult with your doctor before starting treatment with Viraday (Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz).

Precautions
Viraday tablet may increase the risk of lactic acidosis.

This medication may increase the risk of immune reconstitution syndrome.

Close monitoring of body fat distribution and body weight is required during treatment with this medicine.

This medication should be used with caution in some patients because it may increase the risk of CNS side effects like drowsiness, hallucinations, etc.

Cautions
Do not drive or operate heavy machinery.

Do not crush or break the tablet.

Not safe for pregnant women.

Do not breastfeed while receiving this medication.

DESCRIPTION

  • Composition : Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
  • Manufacturer: Cipla
  • Indication: Anti HIV
  • Packaging: Bottle
  • Dosage Form: Tablet

PACKAGE

  • 200mg
  • 300mg
  • 600mg
Top
    wpChatIcon